Home/ Services/ Healthcare Industry/ Stem Cell / Exosome Production Facilities
ADVANCED BIOLOGICAL PRODUCTION

Stem Cell & Exosome Production Facilities

Purpose-designed controlled environments for cell processing, conditioned media handling, exosome isolation, purification, formulation and quality control.

Closed cell processingTFF purificationAseptic filling
Request a feasibility study ↗
VISION ADVANCED BIOPROCESS PLATFORMCulture · isolation · purification · characterization · fill & finish
Closed processContamination-controlled workflow
ScalableResearch to production scale
CharacterizedIdentity, purity and potency strategy
TurnkeyPlant, process and training

From facility concept to operational transfer.

Infinity IVD coordinates architectural planning, clean-room engineering, process equipment, utilities, qualification, documentation and personnel training around the intended research or manufacturing scope.

01

Facility & Clean-Room Design

Personnel and material flows, gowning, airlocks, controlled suites, pressure cascades, HVAC, HEPA filtration and environmental monitoring.

02

Cell Processing Infrastructure

Biosafety cabinets, CO₂ incubators, centrifugation, cell counting, microscopy, controlled-rate freezing and cryogenic storage.

03

Exosome Isolation & Purification

Clarification, filtration, tangential-flow filtration, ultracentrifugation or chromatography workflows selected for scale and purity.

04

Formulation, Filling & Storage

Controlled formulation, aseptic handling, filling, labeling, cold storage and qualified frozen-storage solutions.

05

Quality Control Laboratory

Identity, particle size and concentration, sterility, mycoplasma, endotoxin, viability, protein markers and release testing.

06

Utilities & Support Systems

Required water systems, process gases, clean compressed air, cold chain, backup power and monitored storage.

07

Qualification & Documentation

URS, DQ, IQ/OQ, SOP framework, batch records, maintenance and calibration plans.

08

Technology Transfer & Training

Process mapping, equipment operation, contamination control, QC methods, trial batches and operational handover.

A complete advanced-therapy manufacturing ecosystem.

Equipment is configured around the selected cell source, culture format, batch scale, isolation strategy, final presentation and applicable quality pathway.

01

Class II biosafety cabinets

02

Closed cell-processing workstations

03

CO₂ incubators and cell factories

04

Single-use bioreactor systems

05

Refrigerated centrifuges

06

Tangential-flow filtration skids

07

Chromatography and ultrafiltration

08

Particle analysis and flow cytometry

09

Automated aseptic vial filling

10

Controlled-rate freezers

11

−80°C and cryogenic storage

12

Environmental monitoring

Evidence from starting material to final preparation.

The final panel is selected for product type and intended use. A representative program may include:

Cell identity & viabilitySterilityMycoplasmaEndotoxinParticle size & countSurface markersResidual impuritiesPotency strategyContainer integrityStability

Controlled from source to final preparation.

01Cell source & qualification02Expansion & conditioning03Harvest & clarification04Isolation & purification05Characterization & QC06Formulation & storage

The exact process, biosafety level, clean-room classification and release criteria depend on intended use and applicable national requirements.

Plan an exosome facility ↗
WhatsApp